Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Veritas In Silico

Veritas In Silico

130A · TSE · Pharmaceutical

Financials Company only

Revenue¥91.1m−53.2% year on yearCompany only · FY12/25

Ordinary profit−¥391mCompany only · FY12/25

Performance over time

Revenue
¥59.3mFY12/21
¥179mFY12/22
¥360mFY12/23
¥195mFY12/24
¥91.1mFY12/25
Ordinary profit
−¥240mFY12/21
−¥138mFY12/22
¥35.9mFY12/23
−¥234mFY12/24
−¥391mFY12/25
Op. cash flow
−¥235mFY12/21
−¥149mFY12/22
¥68.7mFY12/23
−¥218mFY12/24
−¥299mFY12/25

People & pay

Employees19 peopleFY12/25

Average salary¥8.37mFY12/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitEPSTotal assetsNet assetsOp. cash flow
FY12/25¥91.1m−53.2% year on year−¥390.6m−¥65.62¥1.88bn¥1.78bn−¥299.3m
FY12/24¥194.6m−46.0% year on year−¥233.6m−¥37.11¥2.25bn¥2.21bn−¥217.9m
FY12/23¥360.4m+101.5% year on year¥35.9m¥6.01¥1.66bn¥1.58bn¥68.7m
FY12/22¥178.8m+201.4% year on year−¥138.5m−¥25.70¥1.60bn¥1.54bn−¥148.8m
FY12/21¥59.3m−¥240.1m−¥51.92¥1.75bn¥1.68bn−¥235.0m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100XSIT · Japan GAAP. Each figure's years come from one report's five-year summary.